PlainRecalls
FDA Drug Moderate Class II Terminated

Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Amgen Manufacturing Ltd., a subsidiary of Amgen Inc., Thousand Oaks, CA 91320-1799,NDC 55513-710-01, UPC 3 55513 71001 5.

Reported: November 13, 2013 Initiated: September 17, 2013 #D-66318-001

Product Description

Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Amgen Manufacturing Ltd., a subsidiary of Amgen Inc., Thousand Oaks, CA 91320-1799,NDC 55513-710-01, UPC 3 55513 71001 5.

Reason for Recall

Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.

Details

Recalling Firm
Amgen, Inc.
Units Affected
4,163 prefilled syringes
Distribution
Nationwide and Puerto Rico, Canada, Mexico, and clinical distribution in Europe.
Location
Thousand Oaks, CA

Frequently Asked Questions

What product was recalled?
Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Amgen Manufacturing Ltd., a subsidiary of Amgen Inc., Thousand Oaks, CA 91320-1799,NDC 55513-710-01, UPC 3 55513 71001 5.. Recalled by Amgen, Inc.. Units affected: 4,163 prefilled syringes.
Why was this product recalled?
Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 13, 2013. Severity: Moderate. Recall number: D-66318-001.